Even minor, consistent improvements in your food choices can lead to noticeable benefits and better outcomes with Semaglutide
,
Recinella L, Orlando G, Ferrante C, Chiavaroli A, Brunetti L, Leone S (2020) Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and Cardiovascular Diseases
Zepbound is primarily approved for weight management and obstructive sleep apnea , but it contains tirzepatidea GLP-1/GIP receptor agonist also used to treat diabetes under the brand name Mounjaro
Elahi et al Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 Receptor Endocrinol
[4] Phase 3 trials (the TRIUMPH programme) are currently underway, with results anticipated in the coming years